Viewing StudyNCT00063609



Ignite Creation Date: 2024-05-05 @ 11:31 AM
Last Modification Date: 2024-10-26 @ 9:09 AM
Study NCT ID: NCT00063609
Status: COMPLETED
Last Update Posted: 2017-09-13
First Post: 2003-07-01

Brief Title: The Effect of Zoledronic Acid on Bone Loss in Prostate Cancer Patients Undergoing Androgen Deprivation Therapy
Sponsor: Novartis Pharmaceuticals
Organization: Novartis

Conditions & Keywords Data

Conditions:
Name
Prostate Cancer
Keywords:
Name View
Androgen Deprivation Therapy View
Prostate Cancer View
Bone Loss View
Osteoporosis View
Bone Mineral Density View